January 29, 2015

Rite Aid reported a 4.8% increase in same-store sales benefiting in part from a strong flu season to date.

 

January 28, 2015

The House Energy and Commerce Committee on Tuesday released a discussion document in the 21st Century Cures initiative.

January 27, 2015

Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to Tuesday’s hearing titled, “Examining Public Health Legislation to Help Patients and Local Communities.”

January 21, 2015

Eisai on Tuesday announced the launch of a new savings card for Belviq (lorcaserin HCl) CIV, the most-prescribed branded FDA-approved prescription drug therapy for chronic weight management.

January 21, 2015

With specialty and biotech drugs claiming an ever-greater share of the pharmaceutical market and spawning a backlash from payers and patients over their high price tags, pharmacy operators are smack in the middle of a growing tug of war between the drug industry, the public and private health plans struggling to keep up with the new drug-cost paradigm.

January 20, 2015

Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

January 16, 2015

Kathleen "Cook" Uhl on Thursday was named director of the Food and Drug Administration's Office of Generic Drugs.

 

January 14, 2015

MedifVU and ProKarma on Wednesday unveiled a new mobile application, i-PharmAssist OTC, a simple consumer-friendly app that provides a list of appropriate over-the-counter medications based on the user's medical history, symptoms and preferences.

January 12, 2015

Shire and NPS Pharmaceuticals have entered into a merger agreement for a total consideration of $5.2 billion.

 

January 8, 2015

Health Mart, an independent pharmacy network with more than 3,600 locally owned community pharmacies across all 50 states, on Thursday launched a national multi-million dollar advertising campaign.

 

January 7, 2015

The pharmaceutical industry is back. Fueled by the launch of expensive, new biotech medicines, rising prices for both branded and generic drugs and a recent slowdown in branded-drug patent expirations and generic competition, the U.S. pharmaceutical market is staging a remarkable resurgence.

January 6, 2015

Gilead Sciences’ Harvoni and Sovaldi drugs will be exclusive to CVS Health’s Standard Commercial, Exchange (Marketplace), Medicare Part D and Medicaid formularies.

January 6, 2015

Vermont Attorney General Bill Sorrell is investigating generic drug price inflation.

December 29, 2014

In a staff memo, the Office of Generics Drug’s acting director, Kathleen Uhl, vowed to take action on 90% of the abbreviated new drug application backlog before October 2017, and has appointed Ted Sherwood as acting director of OGD’s Office of Regulatory Operations to help with the improvements, FDANews.com has reported.

December 18, 2014

The U.S. Senate Special Committee on Aging unveiled a new bipartisan report earlier this week that focuses on ways to increase the use of generic drugs within the Medicare Part D program.

December 18, 2014

UnitedHealthcare has announced the winners of the second annual UnitedHealthcare Medication Adherence Targeted Intervention Program Challenge benefiting the National Association of Chain Drug Stores Foundation.

December 17, 2014

The Generic Pharmaceutical Association on Wednesday expressed concerns that the current structure of the Trans-Pacific Partnership agreement (TPP) will impede generic utilization.

December 15, 2014

Cardinal Health has introduced a new tool that gives pharmacists the ability to rapidly analyze antibiotic use trends.

December 11, 2014

Are high distribution costs and overly complex regulations stifling pharmaceutical and health product suppliers’ ability to fully engage with the fast-changing healthcare marketplace? That’s one concern raised by a global survey of healthcare executives in the United States, Canada, Europe, Asia and Latin America from United Parcel Service.

December 11, 2014

After a recent spike in the prices charged for some generic drugs led to outcries from pharmacists, patient advocates and federal lawmakers, a report issued last month suggests that drug costs can be controlled if the Food and Drug Administration changes the way it handles reviews and approvals.

 
December 11, 2014

Pharmacists, patients and payers must work together to take advantage of med sync tools and help alleviate the issue of medication nonadherence, stated B. Douglas Hoey, CEO of the National Community Pharmacists Association, in a statement issued on Thursday.

December 9, 2014

Reps. Doug Collins, R-Ga., and Dave Loebsack, D-Iowa, introduced on Tuesday H.R. 5815 — the Generic Drug Pricing Fairness Act — which creates greater transparency in how PBMs reimburse pharmacies for generic prescription drugs under Medicare Part D, the military’s TRICARE program, and the Federal Employees Health Benefits Program.

December 5, 2014

The FDA issued a draft guidance that would provide generic companies a pathway to obtain samples of medicines requiring a Risk Evaluation and Mitigation Strategy (REMS) protocol for product testing.

December 3, 2014

The Food and Drug Administration published a final rule that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products.